Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Tadalafil impurity 2 is a chemical impurity associated with Tadalafil, functioning as a byproduct in its synthesis. This compound is primarily utilized in quality control and analytical studies to ensure the purity of pharmaceutical preparations. Its presence may affect the efficacy and safety profile of Tadalafil-containing formulations, making it critical in drug development and regulatory assessments. -
Drug Impurity
Acyclovir impurity 4 is a chemical impurity associated with the antiviral agent Acyclovir. This compound is primarily used in the context of analytical chemistry for the assessment of drug purity and quality control in pharmaceutical formulations. Research applications include method development for identification and quantification of impurities in Acyclovir samples, contributing to the overall safety and efficacy evaluation of antiviral therapies. -
Drug Impurity
Atenolol impurity 9 is a chemical impurity related to the antihypertensive agent Atenolol. This compound is primarily utilized in pharmaceutical research to assess the purity and stability of Atenolol formulations. Its characterization is essential in ensuring compliance with regulatory standards for drug quality and safety. -
Drug Impurity
Febuxostat impurity 13 is a known impurity associated with the drug Febuxostat, which is a selective inhibitor of xanthine oxidase. This impurity is significant for quality control and method development in pharmaceutical research. Its analysis can aid in understanding the compound's stability, purity, and overall quality in formulations, contributing to the regulatory compliance of pharmaceutical products. -
Drug Impurity
N-Trityl candesartan cilexetil is identified as a drug impurity associated with the angiotensin II receptor antagonist class of compounds. Its presence may affect the pharmacological profile and efficacy of the primary drug. This reagent is valuable for analytical studies in drug development and quality control, particularly in evaluating the purity of candesartan cilexetil formulations. -
Drug Intermediate Control
Ethyl-2-(2-pyridyl)-4-(bromomethyl)-Thiazole-5-Carboxylate serves as a valuable synthetic intermediate in pharmaceutical synthesis. This compound exhibits potential utility in the development of novel therapeutic agents, enabling the creation of complex thiazole derivatives. Its application is essential in drug discovery processes focused on various biological targets, allowing researchers to explore new pathways in medicinal chemistry. -
Drug Intermediate
tert-Butyl 4-(1H-indol-4-yl)piperazine-1-carboxylate functions as a synthetic intermediate in pharmaceutical synthesis. This compound is valuable for the development of various bioactive molecules due to its piperazine and indole functionalities, contributing to the modulation of diverse biological targets. Its application is essential in drug discovery and development processes. -
Drug Impurity
Prednisolone Impurity 1 is a known impurity associated with the corticosteroid prednisolone. It serves as an important reference standard for analytical methods and quality control processes in pharmaceutical research. Its characterization and quantification are crucial for ensuring the purity and efficacy of prednisolone formulations. This reagent is widely utilized in stability studies and method development for drug formulation analysis. -
Drug Impurity
Mirabegron impurity 11 is a specific impurity associated with the pharmaceutical agent Mirabegron, a β3-adrenergic agonist. This compound may serve as a valuable reference standard in the quality control and analytical assessment of Mirabegron formulations. Researchers can utilize this impurity for studies related to pharmacokinetics, stability testing, and regulatory compliance in drug development. -
Drug Impurity
Rivaroxaban impurity 14 is an identified impurity of the anticoagulant Rivaroxaban, primarily targeting factor Xa. This impurity can be utilized in analytical and quality control studies to assess the purity of Rivaroxaban formulations. Its presence is important for regulatory compliance and to ensure the safety and efficacy of drug products in development and production. -
Drug Impurity
Moxifloxacin impurity 3 (6,8-Dimethoxymoxifloxacin) is identified as a drug impurity of Moxifloxacin. This compound is relevant for analytical chemistry and pharmaceutical development, specifically for quality control and stability testing of Moxifloxacin formulations. Its characterization can provide insights into the stability and degradation pathways of the primary drug substance. -
Drug Impurity
Dabigatran impurity 80 is a chemical impurity associated with the anticoagulant drug Dabigatran. This reagent serves as a critical reference standard for analytical studies, quality control assessments, and impurity profiling in pharmaceutical research. Its presence in drug formulations can impact efficacy and patient safety, making it essential for stability testing and regulatory compliance in the development of Dabigatran-containing products. -
Drug Impurity
Febuxostat impurity 9, also known as Desisobutyl febuxostat, is a chemical impurity associated with the drug Febuxostat. It is primarily relevant in the context of pharmaceutical research and development, particularly in the evaluation of drug purity and safety. This impurity can be employed in studies assessing the metabolism and pharmacokinetics of Febuxostat, aiding in the understanding of potential effects and interactions within biological systems. -
Gentamicin sulfate Impurity
2-Deoxystreptamine dihydrobromide serves as an impurity of Gentamicin sulfate, a broad-spectrum aminoglycoside antibiotic. This compound is of significant interest in the quality control and analysis of Gentamicin formulations, enabling researchers to assess purity and identify potential contaminants. Its study is crucial for understanding the pharmacological profile and safety assessment of aminoglycosides in therapeutic applications. -
Drug Intermediate
3-Methoxy-4-(methoxymethoxy)aniline serves as a key pharmaceutical intermediate with applications in the synthesis of histone deacetylase (HDAC) inhibitors. This compound's structure facilitates the development of various bioactive molecules, enabling the exploration of therapeutic strategies in cancer and other diseases associated with epigenetic regulation. Its role in drug discovery makes it an important reagent for researchers focused on epigenetic therapies. -
Drug Impurity
Mebendazole impurity 4 is a chemical impurity resulting from the synthesis of Mebendazole. It serves as a crucial reference standard in pharmaceutical research and development, particularly in the assessment of drug purity and quality control. This impurity helps to ensure the reliability of analytical methods and supports compliance with regulatory standards in drug manufacture. -
Drug Impurity
Nintedanib impurity 8 is a chemical impurity associated with Nintedanib, a multi-targeted receptor tyrosine kinase inhibitor. This compound serves as a reference standard in the analysis of drug quality, stability, and formulation development. Its characterization aids in understanding the impurity profile of Nintedanib, contributing to regulatory compliance in pharmaceutical research and development. -
Drug Impurity
Ethinylestradiol impurity 6 (6-Oxo-ethinylestradiol) is a known impurity in the synthesis of Ethinylestradiol. This compound serves as a critical reference standard for quality control and method validation in pharmaceutical research. Its characterization is essential for understanding the purity of Ethinylestradiol formulations and ensuring compliance with regulatory standards during drug development. -
Drug Impurity
Azilsartan impurity 13 is a chemical impurity associated with Azilsartan, an angiotensin II receptor antagonist. This compound may be utilized in the analytical characterization of pharmaceutical formulations to ensure compliance with regulatory standards. Its presence in drug development studies offers insights into the quality control and stability of Azilsartan-related products. -
Drug Impurity
Escitalopram impurity 2, also known as (S)-Citalopram N-oxide, is a recognized impurity associated with the selective serotonin reuptake inhibitor, Escitalopram. This compound is essential for quality control and method validation in pharmaceutical research and development. Its presence is vital for studies investigating the pharmacokinetics and toxicity of Escitalopram, contributing to the assessment of drug safety and efficacy profiles. -
Drug Impurity
Lopinavir impurity 15, also known as Lopinavir impurity J, is a known impurity associated with the antiretroviral drug Lopinavir. This compound is relevant for quality control and characterization of Lopinavir formulations in pharmaceutical research. Its presence can impact drug efficacy and safety profiles, making it important for researchers engaged in the development and analysis of antiviral therapies. -
Drug Impurity
Losartan impurity 1, also known as N-Trityl losartan carboxaldehyde, is a chemical impurity associated with the antihypertensive drug Losartan. This compound is significant for quality control in pharmaceutical manufacturing and development, particularly in the assessment of drug purity and safety. Its characterization aids in understanding the stability and efficacy of Losartan formulations, making it an essential reagent for analytical chemistry applications in drug development. -
Drug Impurity
Donepezil impurity 12 is a known impurity of the acetylcholinesterase inhibitor Donepezil. This compound is utilized primarily in pharmacological research for analytical purposes, such as assessing the quality and purity of Donepezil formulations. Its characterization aids in understanding the stability and safety profiles of Donepezil-based therapies. -
Drug Impurity
Ropinirole impurity 6 is a known impurity associated with Ropinirole, a dopamine D2 receptor agonist. This compound is significant for quality control and characterization in pharmaceutical research, particularly for studies focused on the synthesis and analysis of Ropinirole and its related compounds. Its identification and quantification are essential for ensuring the purity and safety of Ropinirole formulations in drug development. -
Drug Impurity
Bupropion impurity 10 is a designated impurity of the antidepressant compound Bupropion. Its characterization is vital for ensuring the quality and safety of pharmaceutical formulations that include Bupropion. This reagent serves as an important reference for analytical studies, including impurity profiling and stability testing in drug development processes. -
Drug Impurity
Ibuprofen impurity 2, also known as Ibuprofen EP impurity G, is a structural impurity associated with Ibuprofen. This compound is primarily used for quality control and characterization in pharmaceutical research. Its presence is essential for assessing the purity and safety profiles of Ibuprofen formulations, contributing to comprehensive drug development and regulatory compliance. -
Drug Impurity
Aripiprazole impurity 18 is a chemical impurity associated with the antipsychotic drug Aripiprazole. Its presence may be of interest in pharmaceutical research and development, particularly in the quality control of drug formulations. This impurity can be utilized in analytical studies to assess the purity and stability of Aripiprazole, aiding in the development of more effective therapeutic agents. -
Drug Impurity
4-Biphenylmethanol is recognized as a drug impurity, primarily influencing the purity assessment of pharmaceutical compounds. Its presence can impact the pharmacokinetics and overall efficacy of drug formulations. This compound serves as a crucial reference in analytical chemistry for the characterization and quantification of related substances in various drug development processes. -
Drug Impurity
Rivaroxaban impurity 27 is a characterized impurity of the anticoagulant drug Rivaroxaban. It serves as a critical reference standard for the analysis and quality control of Rivaroxaban formulations. The identification and quantification of this impurity are essential for ensuring compliance with regulatory standards in pharmaceutical research and development. -
Drug Impurity
Trimetazidine impurity 2 is a known impurity of the antianginal agent Trimetazidine, which primarily acts by enhancing myocardial metabolism. This compound is useful for analytical applications, particularly in the assessment of drug purity and development. It plays a critical role in quality control and regulatory compliance within pharmaceutical research, ensuring the integrity of active pharmaceutical ingredients. -
Drug Impurity
Rivaroxaban Impurity 39 is a known impurity associated with Rivaroxaban, an anticoagulant that targets Factor Xa to inhibit thrombin generation. This impurity is important for quality control and characterization in pharmaceutical research and development, ensuring the safety and efficacy of Rivaroxaban formulations. Its analysis can facilitate compliance with regulatory standards during the drug approval process. -
Drug Impurity
Rivaroxaban impurity 12 is a chemical impurity associated with Rivaroxaban, an anticoagulant that targets factor Xa in the coagulation pathway. This impurity is significant for analytical and quality control studies in pharmaceutical research, particularly in the evaluation of Rivaroxaban formulations. Its characterization is essential for ensuring the purity and efficacy of anticoagulant therapies. -
Drug Impurity
Ibuprofen impurity 12 is a chemical impurity associated with Ibuprofen. As a key component in assessing the purity of pharmaceutical formulations, it plays a significant role in quality control and stability testing. Researchers can utilize this impurity for method validation in analytical chemistry, ensuring compliance with regulatory standards in drug development and manufacturing processes. -
Drug Impurity
Regorafenib Impurity 1 is a chemical byproduct associated with Regorafenib. It serves as a reference standard in the analysis and quality control of the primary compound. This impurity is utilized in pharmaceutical research to ensure the purity and efficacy of drug formulations, contributing to the overall understanding of Regorafenib's safety and performance in clinical applications. -
Drug Impurity
Empagliflozin impurity 83 is a characterized impurity associated with the SGLT2 inhibitor Empagliflozin. It serves as an important reference standard in the analysis of drug purity and quality control. This compound is essential for researchers engaged in the development of pharmaceuticals, particularly in ensuring the integrity and compliance of SGLT2 inhibitor formulations. -
Drug Impurity
Abacavir Impurity 2 is a known impurity associated with the antiretroviral drug Abacavir, primarily impacting its pharmacological profile. This compound is essential for quality control and analytical studies focused on drug development, particularly in ensuring the purity and safety of Abacavir formulations. Its characterization is crucial for regulatory compliance and the understanding of potential side effects related to Abacavir therapy. -
Drug Impurity
Arolol impurity 4 is identified as a drug impurity with potential significance in pharmaceutical research. It is utilized for assessing the purity and stability of Arolol formulations, contributing to the understanding of drug quality and safety. Its application is crucial in the development and validation of analytical methods in drug formulation studies. -
Drug Impurity
Trimetazidine impurity 3 is a chemical impurity associated with Trimetazidine. It is primarily relevant in the context of pharmaceutical research and quality control, providing insight into the compound’s stability and potential effects. Understanding its profile is crucial for ensuring the purity and efficacy of Trimetazidine in drug formulations. This impurity serves as an important analytical standard for researchers studying drug metabolism and development. -
Drug Impurity
Clopidogrel impurity 12 is a structural impurity associated with the anticoagulant Clopidogrel, primarily arising during synthesis. This compound is crucial for analytical studies related to pharmaceutical quality control and stability testing. It serves as a reference standard for assessing the purity of Clopidogrel and can be utilized in research to understand the profile of impurities in pharmaceutical formulations. -
Drug Impurity
Candesartan impurity 12 is a specific impurity associated with Candesartan, an angiotensin II receptor blocker. This compound is essential for quality control and method development in pharmaceutical research, particularly in assessing the purity and stability of Candesartan formulations. It aids in the identification and quantification of impurities, thereby ensuring compliance with regulatory standards in drug development. -
Drug Impurity
Sitagliptin impurity 21 is a characterized impurity associated with the DPP-4 inhibitor Sitagliptin. It is essential for quality control and stability studies in the pharmaceutical development of Sitagliptin. This impurity can be utilized in method validation and impurity profiling to ensure the safety and efficacy of drug formulations. -
Drug Impurity
Estradiol impurity 5, also known as Estradiol 17-butyrate, is a characterized impurity derivative of estradiol. This compound is utilized primarily in analytical and quality control settings to assess the purity of estradiol formulations. It serves as a reference standard for studies involving steroid hormones and may be important in pharmacokinetic and pharmacodynamic research. -
Lincomycin Impurity
(2S,4R)-1-methyl-4-propylpyrrolidine-2-carboxylic acid hydrochloride is a structural impurity of Lincomycin, a widely used antibiotic. This compound may aid in the qualitative and quantitative analysis of Lincomycin, assisting researchers in the investigation of its synthesis and stability. It is valuable for quality control and method development in pharmaceutical research. -
Drug Impurity
Apixaban impurity 25 is a byproduct of the anticoagulant Apixaban, primarily serving as a drug impurity standard in analytical chemistry. It is essential for the characterization and quality control of Apixaban formulations, enabling researchers to assess purity and compliance with regulatory standards. This impurity plays a critical role in the development and validation of analytical methods necessary for the evaluation of pharmaceutical products. -
Drug Impurity
Ramipril impurity 11 is a known impurity associated with the ACE inhibitor Ramipril. This compound is utilized primarily in pharmaceutical research to assess the purity of Ramipril formulations and support compliance with regulatory standards. Its characterization is crucial for ensuring the safety and efficacy of drug products containing Ramipril. -
Drug Impurity
Salmeterol impurity 1, also known as Salmeterol impurity A, is a characterized impurity associated with Salmeterol, a long-acting beta-2 adrenergic agonist. This compound is utilized in pharmaceutical research to assess the purity and quality of Salmeterol formulations. Its identification and quantification are essential for ensuring compliance with regulatory standards in drug development and manufacture. -
Drug Impurity
Sitagliptin impurity 7 is a known impurity associated with Sitagliptin, a DPP-4 inhibitor used in the treatment of type 2 diabetes. This compound is essential for the quality control and stability testing of pharmaceutical preparations containing Sitagliptin. Its presence and quantification can help ensure compliance with regulatory standards during drug development and manufacturing processes. -
Drug Impurity
Rosuvastatin impurity 31 is a known impurity associated with Rosuvastatin. This compound is critical for analytical and quality control applications in pharmaceutical research, facilitating the assessment of drug purity and stability. Its characterization is essential for understanding the pharmacokinetic properties and potential biological effects of Rosuvastatin formulations. -
Drug Impurity
Terbinafine impurity 3 hydrochloride is a drug impurity associated with the antifungal agent Terbinafine hydrochloride. This compound serves as a valuable reference standard in pharmaceutical research and development, particularly in the analysis of drug purity and stability. Its characterization is essential for ensuring quality control in the manufacturing process of Terbinafine formulations. -
Drug Impurity
Bupropion impurity 7 is a drug impurity associated with the pharmacological agent Bupropion. This compound is utilized primarily for analytical and quality control purposes, providing a benchmark for the assessment of Bupropion synthesis and purity. Its characterization is crucial in ensuring compliance with pharmaceutical standards and regulations during drug development and manufacturing processes.
